Company Overview
About Pathway Genomics
Pathway Genomics (also known as Pathway OME) is a privately held clinical genetic testing company founded in 2008 and headquartered in San Diego, California. The company operates a CAP-accredited and CLIA-certified clinical laboratory that provides physicians and patients with actionable, precision healthcare information derived from genetic analysis. Pathway's testing services cover cancer risk assessment, cardiac health, pharmacogenomics (drug response), inherited disease risk, nutrition and exercise response, and reproductive health — enabling personalized healthcare decisions grounded in genetic data.
Business Model & Competitive Advantage
Pathway Genomics serves both direct-to-physician and direct-to-consumer channels, providing clinically validated genetic insights that help healthcare providers optimize treatment plans and patients better understand their hereditary health risks. The company's cancer risk panels assess pathogenic variants associated with conditions including hereditary breast and ovarian cancer (BRCA1/2), Lynch syndrome, and familial hypercholesterolemia. Its pharmacogenomics panels help physicians select appropriate medications and dosages based on individual genetic drug metabolism profiles, reducing adverse drug events.
Competitive Landscape 2025–2026
Pathway Genomics operates in a competitive genetic testing market alongside companies like Invitae, GeneDx, Color, and Myriad Genetics. The company differentiates through its broad multi-panel testing menu, its CLIA/CAP accreditation ensuring clinical-grade accuracy, and its physician-facing portal that integrates genetic insights into clinical workflows. While the company remains privately held and has a smaller profile than some genetic testing peers, it continues to serve an active network of physicians and patients seeking actionable genetic health information.
Key Differentiators
Strong Challenger
Pathway Genomics is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Compare Pathway Genomics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Pathway Genomics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Pathway Genomics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pathway Genomics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →